West Pharmaceutical Services, Inc., a global manufacturer of pharmaceutical delivery products and solutions, has introduced the Verux line of pharmaceutical packaging components for the Asia Pacific market.
This dedicated brand of fit-for-purpose stoppers and seals for injectable drug products provides quality packaging solutions for local pharmaceutical and biotechnology companies, the company said in a statement.
By leveraging Wests more than 90 years of expertise in advanced production technologies and global regulatory compliance, and our knowledge base of drug product testing, development, packaging and delivery expertise, were able to provide this tailored solution, said Mike Schaefers, Vice President, Product Management and Marketing Operations, West Pharmaceutical Services.
Verux components offer an affordable option for customers to help ensure the medicines they make are safely and effectively delivered to patients, he added.
Faced with increasing scrutiny from regulatory agencies to ensure consistent drug product quality, Asia Pacific drug manufacturers are seeking cost-effective solutions for safe, effective pharmaceutical packaging that meet regulatory requirements, said Troy Player, Vice President and Managing Director, Asia Pacific.
Packaging components play a critical role in ensuring the consistency and quality of injectable drug products. Compromised packaging can lead to a number of adverse consequences, including disruptions in production, resulting in inconsistencies in the final product that can potentially pose risk to patients, Player said.
According to the company, Wests new portfolio of Verux brand pharmaceutical packaging components is designed to offer local drug manufacturers fit-for-purpose, quality packaging components that can help reduce variation and non-conformity of end products.
The company claims to have produced Verux components under stringent processes and controls to meet local and global quality requirements.
Headquartered in Pennsylvania, US, West Pharmaceutical Services registered sales of $1.4 billion in 2015. Its components and devices are designed to improve the delivery of healthcare to patients around the world.